By Jeff Overley (March 1, 2016, 7:59 PM EST) -- The U.S. Food and Drug Administration on Tuesday announced plans to study the use of animation in television commercials for prescription drugs, expressing concern that cartoon characters may muddle messages about benefits and risks.
The FDA cited a cartoon character used for Novartis' toenail infection drug Lamisil in its notice Tuesday.
In a public notice, the FDA referred to a number of prescription drugs that have used animated advertisements over the years. Despite that history, many questions remain about how viewers process the ads, the notice said.
"To our knowledge, no studies have comprehensively examined how animation affects consumers' benefit and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!